SLC46A1 and glioma: Our findings support the hypothesis that FA is a suitable ligand candidate in the development of drugs for targeted treatment of certain gliomas, expressing high levels of folate receptors and/or PCFT, and could provide successful and specific internalization of nanoparticulate drugs.